P581: Complementary and alternative therapies for inflammatory bowel disease
ECCO '19 Copenhagen
2019
P582: Effectiveness and nephrotoxicity of long-term tacrolimus administration in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P583: Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on adalimumab
ECCO '19 Copenhagen
2019
P584: Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis
ECCO '19 Copenhagen
2019
P585: Efficacy of iDose dashboard forecast for individualising Infliximab therapy: an Indian experience
ECCO '19 Copenhagen
2019
P586: Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: a multi-centre retrospective cohort study
ECCO '19 Copenhagen
2019
P587: Quality of care indicators in inflammatory bowel disease: local pilot study
ECCO '19 Copenhagen
2019
P588: Tacrolimus suppositories: a safe and effective treatment for treatment-refractory proctitis
ECCO '19 Copenhagen
2019
P589: A population pharmacokinetic model to improve mucosal healing upon golimumab induction therapy in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P591: Low donor microbial engraftment after combined endoscopic and oral faecal microbiota transplant (FMT) in patients with antibiotic dependent pouchitis
ECCO '19 Copenhagen
2019
P592: Towards a Food Pharmacy: increased dietary quality reduces CRP and improves quality of life in IBD patients in remission
ECCO '19 Copenhagen
2019
P593: A national database study on colectomy and colorectal cancer in ulcerative colitis: what is the role of appendectomy?
ECCO '19 Copenhagen
2019
P594: Predictors of non-response to repeated faecal microbiota transplantation in patients with therapy refractory ulcerative colitis
ECCO '19 Copenhagen
2019
P595: Early medical therapy and risk of subsequent perianal fistula development among paediatric patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P596: An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD
ECCO '19 Copenhagen
2019
P597: Optimising therapeutic drug monitoring of adalimumab with dried blood samples in IBD patients: an interim analysis
ECCO '19 Copenhagen
2019
P598: Safety and effectiveness of adalimumab treatment in 1523 patients with ulcerative colitis: Results from a prospective, multi-centre, observational study
ECCO '19 Copenhagen
2019
P599: Development of an inflammatory bowel disease-specific nutrition screening tool (IBD-NST)
ECCO '19 Copenhagen
2019